Reducing Cardiovascular Risk in Patients With Diabetes Robert J Bulgarelli DO FACC CMA Director Integrative Cardiology - MLHS CMO – the Habit Change Company.
Introduction Cerebrospinal fluid (CSF) –What is it? –What does it do? –Disorders The Blood Brain Barrier (BBB) –What is it? –What does it do? –Disorders.
Glucose (mg/dl) 50 – 100 – 150 – 200 – 250 – 300 – 350 – 0 – 50 – 100 – 150 – 200 – 250 – -10-5051015202530 Years of diabetes Burger HG, et al. 2001. Diabetes.
Sodium metabolism
Laboratory diagnosis of meningitis
Care of the Patient with Diabetes in Haiti (French) Symposia
Massive transfusion
A. Update on Type 2 Diabetes. Natural History of Type 2 Diabetes Adapted from: International Diabetes Center (Minneapolis, Minnesota). Insulin resistance.
Body Fluids
Program Intervensi Sidartawan
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
ERSD: END STAGE RENAL DISEASE Kathryn Atwater PVAMU Intern 2012-2013.
